Search…

Lates News

27/08/2025

According to Every Rights AI, on August 27th, Guojin Securities issued a research report giving a buy rating to Heart Medical (688016.SH). The reasons for the rating mainly include: 1) outstanding innovative research and development capabilities, with multiple product lines making breakthroughs; 2) rapid international expansion, with Talos achieving overseas sales for the first time. (Daily Economic News)

Latest

3 m ago

Haohen Motors and Electronics: Currently, the company has sufficient orders in hand.

3 m ago

The trading volume of the three cities Shanghai, Shenzhen, and Beijing exceeded 1.9 trillion yuan, which was 752 billion yuan higher than the same time the previous day.

3 m ago

Haowen Auto Electric: Has reached a strategic chip cooperation with NVIDIA and fully entered the development of robot brain control system.

4 m ago

Every economic AI flash news, Huayuan Securities released a research report on August 27th, giving Wanmei Biology (603983.SH) a buy rating. The reasons for the rating mainly include: 1) Continuously promoting the high-quality development of dual-brand synergy; 2) The online channel is gaining momentum, and refined operation is carried out on multiple platforms; 3) The company's profitability has decreased slightly, and the sales expense ratio has continued to rise. (Daily Economic News)

4 m ago

Hong Kong-listed innovative pharmaceutical stocks continue to decline, with many stocks such as Zhaoyan Pharmaceuticals falling by more than 3%.

See all latest